Simulations Plus Company Insiders

SLP Stock  USD 12.12  -0.32  -2.57%   
Simulations Plus employs about 212 people. The company is managed by 29 executives with a total tenure of roughly 8 years, averaging almost 0.0 years of service per executive, having 7.31 employees per reported executive. A leadership review of Simulations Plus matters because management quality often shapes how effectively strategy is translated into revenue growth, margins, and cash generation. Used properly, management analysis helps separate durable execution from results that may only reflect a supportive market cycle.

Simulations Plus' Workforce Through the Years

Historical employee data for Simulations Plus can give investors another way to assess whether the business is scaling, restructuring, or stabilizing across different operating conditions. Current projections suggest a workforce around slightly above 210 employees by April 2026, which should be reviewed alongside revenue and margin trends.
Macro event markers
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes

Management Team Effectiveness

The company has Return on Asset of 2.79 % which means that it generated a profit of $2.79 on every $100 of assets employed. This is lower than peers in the sector. In the same way, it shows a return on shareholders' equity (ROE) of -41.21 %, which indicates that equity investment in it has not been earning a positive return.
As of earlier this week, Net Income Applicable To Common Shares is projected to grow to approximately 15.1 M, whereas Common Stock Shares Outstanding is moving lower toward slightly above 17.2 M.

Stock Institutional Investors

Simulations Plus has 85.97% institutional ownership and a 17.31% insider stake. Annual revenue is about 79.18 Million. That ownership mix shapes how the stock trades around earnings and sector rotation. The business currently sits in the Health Care sector and the Health Care Equipment & Services industry. Watching turnover and volume trends alongside ownership data adds depth to the picture.
Shares
Geode Capital Management, Llc2025-12-31
399.8 K
Kennedy Capital Management Inc2025-12-31
398.9 K
State Street Corp2025-09-30
398.5 K
Bank Of America Corp2025-09-30
369.6 K
Dimensional Fund Advisors, Inc.2025-12-31
348.2 K
Meros Investment Management, Lp2025-12-31
339.2 K
Jpmorgan Chase & Co2025-09-30
335.3 K
Sio Capital Management, Llc2025-09-30
320.3 K
Citadel Advisors Llc2025-12-31
277 K
First Light Asset Management, Llc2025-12-31
M
Morgan Stanley - Brokerage Accounts2025-09-30
1.3 M
At 250.62 Million, Simulations Plus sits in smaller-cap territory where institutional context matters most alongside valuation and volatility readings. The business currently sits in the Healthcare sector and the Health Information Services industry. Reading Simulations Plus holder concentration alongside float turnover and volatility adds the best context for understanding how smaller-cap ownership shapes price.

Insider Trading Activities

Insider trading disclosures for Simulations Plus offer a structured way to watch how people closest to the business are behaving while expectations change across the market. Most U.S. insider trades are disclosed through Form 4 reporting, which is why the value here comes from reading the sequence of filings, not one isolated transaction.
 
Woltosz Walter S a day ago
Disposition of 2600 shares by Woltosz Walter S of Simulations Plus at 24.62 subject to Rule 16 b-3
 
Weiner Daniel L over three weeks ago
Acquisition by Weiner Daniel L of 1776 shares of Simulations Plus subject to Rule 16 b-3
 
Fiedler-kelly Jill over a month ago
Disposition of 8950 shares by Fiedler-kelly Jill of Simulations Plus at 9.71 subject to Rule 16 b-3
 
Dibella John Anthony Ii over three months ago
Acquisition by Dibella John Anthony Ii of 27500 shares of Simulations Plus at 16.02 subject to Rule 16 b-3
 
Woltosz Walter S over three months ago
Disposition of 20000 shares by Woltosz Walter S of Simulations Plus at 15. subject to Rule 16 b-3
 
Woltosz Walter S over six months ago
Disposition of 12224 shares by Woltosz Walter S of Simulations Plus at 18.58 subject to Rule 16 b-3
 
Weiner Daniel L over six months ago
Disposition of 750 shares by Weiner Daniel L of Simulations Plus at 28.5 subject to Rule 16 b-3
 
Evans Sharlene over a year ago
Acquisition by Evans Sharlene of 662 shares of Simulations Plus subject to Rule 16 b-3
 
Weiner Daniel L over a year ago
Acquisition by Weiner Daniel L of 735 shares of Simulations Plus subject to Rule 16 b-3
 
Weiner Daniel L over a year ago
Disposition of 750 shares by Weiner Daniel L of Simulations Plus at 28.5 subject to Rule 16 b-3
 
Lavange Lisa over a year ago
Disposition of 650 shares by Lavange Lisa of Simulations Plus at 31.88 subject to Rule 16 b-3
 
Evans Sharlene over a year ago
Acquisition by Evans Sharlene of 735 shares of Simulations Plus subject to Rule 16 b-3

Outstanding Bonds

Outstanding bonds linked to Simulations Plus can tell investors a great deal about how the company finances itself beyond common equity markets. Used together with earnings and cash-flow analysis, the bond stack can reveal whether leverage is a manageable tool or a developing constraint.

Corporate Filings

8K
18th of February 2026
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
9th of February 2026
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
13A
6th of February 2026
The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934
ViewVerify
4th of February 2026
Other Reports
ViewVerify
F4
2nd of February 2026
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
13A
30th of January 2026
The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934
ViewVerify
F4
29th of January 2026
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
10Q
9th of January 2026
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
ViewVerify
The majority of Simulations Plus' outstanding shares are owned by institutional holders. High institutional ownership often reflects the stock's eligibility for passive index funds, which are required to hold positions proportional to index weights regardless of their own investment view. Active managers holding Simulations Plus must also disclose positions above certain thresholds through SEC filings. The 86% institutional stake in Simulations Plus compares to 17% held by insiders and 0% by retail investors.
 
Shares in Circulation  
 First Issued
1996-12-31
 Previous Quarter
20.1 M
 Current Value
20.2 M
 Average Shares Outstanding
15.9 M
 Quarterly Volatility
4.3 M
Macro event markers
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes

Holders Distribution

Institutional investors in Simulations Plus typically operate with more research capacity, technology, and trading scale than retail holders, which is why their activity can materially affect price behavior. This matters because getting in early on a sponsorship cycle may help, but getting caught near a large-holder exit can have the opposite effect.

Market Cap and Value

Workforce Comparison

Simulations Plus is rated below average for number of employees against industry peers. The total workforce of Health Care industry is at this time estimated at about 3,156. Simulations Plus holds roughly 212 in number of employees claiming about 7% of equities under Health Care sector.

Profit Margins

The company has Net Profit Margin of -82.0 %, which suggests that margin recovery will require either cost cuts or price increases. This places it below most industry peers. In the same way, it shows Net Operating Margin of 4.0 %, which suggests that the company runs its operations efficiently, retaining $4.0 per $100 of revenue.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.570.53
Significantly Up
Slightly volatile

Insider Trading History

The insider-trading timeline for Simulations Plus gives investors a long-run view of how management behavior has tracked against the stock's price action. Investors typically focus on transactions that fall outside standard compensation timelines, as those are more likely to reflect forward-looking conviction.
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2026-03-01
1.0
1
1
8,950
8,950
2025-12-01
3.0
9
3
146,355
29,961
2025-09-01
1.25
5
4
10,370
21,734
2025-06-01
0.5556
5
9
3,930
60,000
2025-03-01
1.0
5
5
3,935
60,000
2024-12-01
2.0
10
5
69,960
61,400
2024-09-01
0.6
6
10
5,925
63,650
2024-06-01
0.5
7
14
7,310
72,800
2024-03-01
0.75
6
8
33,960
61,000
2023-12-01
0.9231
12
13
129,891
222,458
2023-09-01
2.5
5
2
3,010
2,192
2023-06-01
0.8571
6
7
4,095
60,500
2023-03-01
0.625
10
16
69,314
154,463
2022-12-01
1.0
20
20
181,315
217,800
2022-09-01
0.6
6
10
1,638
69,984
2022-06-01
0.4286
6
14
2,250
78,286
2022-03-01
0.3846
5
13
2,145
64,393
2021-12-01
0.2
5
25
1,735
218,500
2021-09-01
0.5556
5
9
1,855
60,000
2021-06-01
0.3333
5
15
1,385
86,000
2021-03-01
0.4815
13
27
46,242
136,584
2020-12-01
1.125
9
8
55,575
168,881
2020-09-01
2.75
11
4
51,030
96,000
2020-06-01
2.0
6
3
2,905
72,000
2020-03-01
1.6667
5
3
2,225
72,000
2019-12-01
1.0
7
7
16,036
216,809
2019-09-01
2.0
12
6
109,445
34,447
2019-06-01
2.0
6
3
21,220
40,000
2019-03-01
3.0
6
2
26,008
37,000
2018-12-01
1.1429
8
7
52,822
168,000
2018-09-01
1.0
4
4
39,570
95,500
2018-06-01
1.25
5
4
30,223
44,991
2018-03-01
0.3077
4
13
19,763
137,000
2017-12-01
1.0
4
4
14,256
145,500
2017-09-01
0.4615
6
13
10,400
205,500
2017-03-01
2.5
5
2
82,100
5,500
2016-12-01
1.0
2
2
16,000
119,000
2016-06-01
1.0
4
4
11,600
11,600
2016-03-01
0.5
1
2
8,700
90,257
2015-12-01
1.0
1
1
12,000
97,000
2014-12-01
2.0
2
1
24,500
4,500
2014-09-01
2.5
5
2
83,200
119,000
2013-09-01
2.0
4
2
15,000
163,000
2012-12-01
1.0
2
2
73,503
133,000
2012-09-01
4.0
4
1
30,000
181,000
2012-03-01
0.75
3
4
61,200
38,400
2011-12-01
0.3333
1
3
100,000
148,450
2011-09-01
1.4
7
5
52,126
86,000
2011-06-01
0.5
1
2
70,000
88,572
2011-03-01
0.3333
1
3
70,000
90,000
2010-12-01
0.25
2
8
70,000
222,635
2010-09-01
0.5455
6
11
36,000
86,398
2009-12-01
1.0
3
3
328,234
285,000
2009-09-01
1.5
12
8
70,060
157,446
2009-06-01
2.0
8
4
86,000
83,205
2008-12-01
1.5
3
2
271,000
207,000
2008-09-01
1.0
8
8
77,000
91,155
2008-03-01
2.5
5
2
115,000
95,000
2007-09-01
0.5
4
8
24,000
44,000
2007-06-01
0.1667
3
18
64,000
4,189,850
2007-03-01
1.0
7
7
66,800
16,000
2004-12-01
0.6
6
10
10,600
40,400

Notable Stakeholders

Stakeholder analysis for Simulations Plus is useful because companies often face trade-offs among groups that want very different outcomes from the same business. This becomes more informative when investors want to understand not just ownership, but influence, incentives, and strategic pressure points.
Steven ChangPresident PharmacologyProfile
Jonathan ChauvinPresident SolutionsProfile
Jill MSPresident SolutionsProfile
Brett HowellPresident SolutionsProfile
William FrederickExecutive CFOProfile
Christina HendricksonDirector MarketingProfile
Erik GuffreyCoChief OfficerProfile
MS MASCoFounder ChairmanProfile
MS MSPres DivisionProfile
Marvin WaldmanSenior FellowProfile
Viera LukacovaChief OfficerProfile
Daniel SzotChief OfficerProfile
Murry AlperGlobal CommunicationsProfile
Michael LawlessSenior ScientistProfile
Josh FoheySenior OperationsProfile
Bud JDVP OfficerProfile
Renie DornbuschChief CommunicationsProfile
Sandra SharpGlobal StrategiesProfile
John MSCheminformatics PBPKProfile
Arlene PadronCorporate MarketingProfile
Jenna RouseGlobal OperationsProfile
Brad StefanovicHead InsightsProfile
Jennifer PresnellAccounting ManagerProfile
Grant FowlerSenior InsightsProfile
Daniel CPAVice FinanceProfile
Shawn OConnorChief OfficerProfile
Scott SilerChief PharmacologyProfile
Tanya MarvinMarketing ManagerProfile
Lindsay LukeExecutive ResourcesProfile

Management Information & Data Sources

Simulations Plus is a micro-cap company in Health Care Technology, Health Care Equipment & Services, Health Care. Executive review focuses on insiders, senior management, and employee signals. Executive background, tenure, and turnover can influence how investors interpret strategic shifts. Simulations Plus employs 212 people.

Unless otherwise specified, data for Simulations Plus is compiled from periodic company reporting and market reference feeds and standardized for comparability. Sell-side coverage, where present, supplements the data shown. Updates may occur throughout the day. Insider and management fields are mapped from published filings and company disclosures.

This content is curated and reviewed by:

Rifka Kats - Member of Macroaxis Editorial Board
Last reviewed on March 8th, 2026

Workforce Efficiency and Productivity

Workforce efficiency at Simulations Plus can help investors judge how effectively labor resources are being converted into revenue and profit over time. The stronger interpretation compares these measures with sector norms because labor intensity varies meaningfully across industries.

Simulations Plus Manpower Efficiency

Return on Simulations Plus Manpower

Revenue Per Employee373.5K
Revenue Per Executive2.7M
Net Loss Per Employee305.3K
Net Loss Per Executive2.2M
Working Capital Per Employee211.4K
Working Capital Per Executive1.5M

Additional Tools for Simulations Stock Analysis

Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Bonds Directory
Find actively traded corporate debentures issued by US companies
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Technical Analysis
Check basic technical indicators and analysis based on most latest market data